10,000 Lawsuits: Actos Injury Filing in Multidistrict Litigation 2299 Streamlined

Judge Rebecca Doherty signed a Direct Filing Order in April that allows any plaintiff to add their lawsuit directly to Actos Multidistrict Litigation 2299. In December 2011, a federal Judicial Panel consolidated several Actos lawsuits under one federal court, in Lafayette, Louisiana. The Honorable Rebecca Doherty is presiding over the … [Read more...]

Judge Doherty extends deadline to file against Actos in MDL 2299

Judge Rebecca Doherty, who is overseeing the Actos multidistrict litigation (MDL) suit 2299 in Louisiana, extended the deadline for plaintiffs to file suits against Takeda Pharmaceuticals. Judge Doherty cited the large number of cases expected to be filed, and the necessity of gathering enough information in each case. She issued a scheduling … [Read more...]

Actos and Bladder Cancer Linked in Two New 2012 Studies

Two recent studies this year show a stronger link between Actos, a drug used in treating Type 2 diabetes, and bladder cancer. In May, a study published in the British Medical Journal showed that using Actos for two years would double a patient’s risk of bladder cancer. A study published in the July edition of the Canadian Medical Association … [Read more...]

Actos Health Questions and Answers

Actos Q: What is Actos? A: Actos is an oral diabetes medicine that helps control blood sugar levels. The drug is prescribed for people with type 2 (non-insulin-dependent) diabetes. Pioglitazone is sometimes used in combination with insulin or other medications, but it is not for treating type 1 diabetes. Q: I’ve heard that the FDA announced Actos … [Read more...]

BestLawyers.comAVBetter Business Bureau